FDA Clears Emerging AI Triage Software for Nine Findings on Abdominopelvic CT
The a2z-Omni-Triage software reportedly facilitates adjunctive triage for a number of findings including pneumothorax, coccygeal fracture, bowel perforation and moderate or severe hydronephrosis.
The Food and Drug Administration (FDA) has issued 510(k) clearance for a2z-Omni-Triage software, an adjunctive AI-powered software for abdominopelvic CT.
A2z Radiology AI, the developer of
• pneumothorax
• moderate or large layering pleural effusion
• complex pleural collection
• bowel perforation
• non-sacral pelvic fracture
• sacral or coccygeal fracture
• soft tissue abscess
• moderate or severe hydronephrosis
• large aortic aneurysm (5 cm or larger)
The a2z-Omni-Triage software may be utilized for contrast-enhanced and non-contrast CT, according to A2z Radiology AI.
“On a busy shift with a long worklist, even a CT ordered as routine can turn out to need urgent attention,” said Michael Moritz, MD, CIIP, Chief Medical Information Officer of a2z Radiology AI. “a2z-Omni-Triage helps bring those studies with suspected findings forward for review.”
Related to this article







